4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-414688
President, Oncology sold 8,333 shares at an average $116.10 ($967,448)
- President, Oncology acquired 8,333 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Vieira Roberto Wandenkolk · President, Oncology
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,333 | $21.63 | $180,243 | 12,279 | D |
| 2026-10-02 | Sale : show line 2 in the form 10b5-1 | −1,100 | $114.52 | $125,973 | 11,179 | D |
| 2026-10-02 | Sale : show line 3 in the form 10b5-1 | −2,086 | $115.73 | $241,412 | 9,093 | D |
| 2026-10-02 | Sale : show line 4 in the form 10b5-1 | −5,147 | $116.59 | $600,063 | 3,946 | D |
| Open-market sales · 8,333 sh · avg $116.10 · $967,448 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) | −8,333 | 133,334 | D |
Loading xslF345X06/ownership.xml…